.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Argus Health
Healthtrust
Merck
Queensland Health
Citi
Moodys
Cantor Fitzgerald
Baxter
Chubb

Generated: November 19, 2017

DrugPatentWatch Database Preview

Mecamylamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for mecamylamine hydrochloride and what is the scope of mecamylamine hydrochloride patent protection?

Mecamylamine hydrochloride
is the generic ingredient in two branded drugs marketed by Targacept and Nexgen Pharma, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for mecamylamine hydrochloride. Three suppliers are listed for this compound.

Pharmacology for mecamylamine hydrochloride

Medical Subject Heading (MeSH) Categories for mecamylamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nexgen Pharma
MECAMYLAMINE HYDROCHLORIDE
mecamylamine hydrochloride
TABLET;ORAL204054-001Mar 19, 2013RXNoYes► Subscribe► Subscribe► Subscribe
Targacept
INVERSINE
mecamylamine hydrochloride
TABLET;ORAL010251-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Moodys
Medtronic
Accenture
Colorcon
Federal Trade Commission
McKinsey
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot